The new year has gotten off with a stunning development, at least for those with no inside knowledge of chain drug retailing. Heyward Donigan, Rite Aid’s chief executive, announced she is leaving the company she joined three years ago.
As a former CVS executive, I took great pleasure in reading about Katie Pouliot, pharmacy manager of CVS Store 212 in Cranston, R.I. Pouliot received the 2022 Paragon Award from CVS Health.
In the conclusion of a two-part interview, Haleon CEO Brian McNamara and Lisa Paley, president of the O-T-C supplier’s North American business, discuss the self-care category’s standing in a post-COVID world.
John Standley’s road was long and winding, but the direction was always upward. Early lack of ambition — his father applied to college for him — did not prevent Standley from ascending to the very heights of chain drug retailing, first as chief executive officer of Rite Aid, and then as president
P&G Beauty and Mielle Organics, a popular textured hair care brand rooted in natural ingredients, announced Wednesday that it will join P&G Beauty, pending regulatory approval, further expanding access to healthy hair products and services for Black women around the world.
Fruth Pharmacy has been making its mark in the industry over the past 70 years by sticking to old-fashioned values and the motto “to do the right thing” as it continues to help take care of its patients and customers.
A key takeaway for our federal and provincial governments in Canada throughout the pandemic was that no matter how daunting, community pharmacy rose to the challenge and delivered.
As we look toward 2023 and a sense of normalcy that has eluded us for the past few years, there are several big things on the horizon to keep an eye on in pharmacy, medication use and high-quality, value-based care.
Specialty pharmacy continues to be dynamic, demanding and disruptive, undergoing rapid and dramatic change.
Walgreens’ overarching strategy is built on a combination of health and wellness expertise and exceptional convenience, says senior vice president and chief merchandising officer Luke Rauch.
Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection.
In recent decades, pharmacy benefit managers have grown into shadowy and hugely influential players in the prescription drug supply chain. For the most part, they have managed to avoid public scrutiny and government regulation.
As the COVID-19 pandemic enters its third year, the public health emergency (PHE) declaration that has underpinned the country’s COVID-19 response efforts by providing the federal government with emergency powers, regulatory flexibilities and additional resources is currently set to expire in early
This week’s Video Forum features two leaders of the newly minted Haleon.
It is easy for those who are not health care professionals to overlook the tremendous potential for innovation in our field today. Similarly, anyone who is not a health policy wonk might not see the important ways policy is evolving to improve the delivery of care for millions of patients.
